Four-Peptide Blend
Contains BPC-157 (10 mg), TB-500 (10 mg), KPV (10 mg), and GHK-CU (50 mg) per vial.
Tissue Repair Peptide Blend
Dragon Pharma Peptide Product
Dragon Pharma Klow is supplied as a lyophilized powder in a 2 mL vial and contains a combination of four peptides: BPC-157, TB-500, KPV, and GHK-CU, with a total labeled strength of 80 mg per vial. Product specifications, storage information, and available payment options are provided below.
Contains BPC-157 (10 mg), TB-500 (10 mg), KPV (10 mg), and GHK-CU (50 mg) per vial.
Supplied as a freeze-dried powder that requires reconstitution with bacteriostatic water before use.
Packaged in a standard 2 mL peptide vial with a rubber stopper and aluminum seal.
Combines four peptides that have been investigated in preclinical research for their potential roles in tissue repair and related processes.
| Product name | Klow 80 mg |
|---|---|
| Active substances | BPC-157 (10 mg), TB-500 (10 mg), KPV (10 mg), GHK-CU (50 mg) |
| Total labeled strength | 80 mg/vial |
| Container | 2 mL vial |
| Total labeled content | 80 mg per vial |
| Product form | Lyophilized powder |
| Manufacturer | Dragon Pharma |
Other peptide options from the same product line include Glow 60 mg, which combines BPC-157, TB-500, and GHK-CU in a different ratio, and individual peptides such as BPC-157 5 mg, TB-500 5 mg, KPV 5 mg, and GHK-CU 10 mg. These products differ in their peptide composition and research applications.
Science & Research
Klow combines four peptides that have each been investigated in preclinical research for their potential roles in tissue repair and related physiological processes. This section provides a brief overview of each peptide and how they are understood in research contexts.
BPC-157 is a synthetic peptide derived from a gastric juice protein. Preclinical research has investigated its potential effects on tissue repair, angiogenesis, and the protection of various tissues. Its mechanism of action is not fully characterized.
TB-500 is a synthetic peptide that corresponds to a fragment of the naturally occurring protein thymosin beta-4. Research has investigated its potential role in cell migration, tissue repair, and cytoskeletal regulation.
KPV is a tripeptide derived from alpha-melanocyte-stimulating hormone (α-MSH). Preclinical research has investigated its potential anti-inflammatory and immunomodulatory effects. Its mechanism of action is not fully characterized.
GHK-CU is a naturally occurring copper-binding peptide that has been studied for its potential effects on tissue repair, wound healing, and related cellular processes. It is found naturally in human plasma and other tissues.
This product is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water or sterile water for injection before use. The addition of water converts the freeze-dried powder into a solution suitable for research applications.
The reconstituted peptide solution should be stored as recommended on the product label. Peptide solutions are typically refrigerated and used within a specified timeframe after reconstitution to maintain integrity.
Peer-reviewed research on BPC-157, TB-500 (thymosin beta-4), KPV, and GHK-CU is available through the National Institutes of Health and other scientific databases. The following links provide general information on these peptides and their mechanisms of action.
Important Health Information
Peptide research compounds such as those in this blend have limited clinical safety data. The information below is derived from published preclinical research and general knowledge of peptide biology and does not constitute medical advice.
BPC-157, TB-500, KPV, and GHK-CU have not been extensively studied in humans. The available safety information comes primarily from preclinical research.
The potential interactions and combined effects of these four peptides have not been characterized in research. The significance of combining them is not fully understood.
Subcutaneous injection carries risks including injection-site reactions, infection and improper technique. Sterile handling and correct reconstitution procedures are essential.
The potential systemic effects of these peptides and their interactions with other physiological systems are not fully understood.
This peptide research compound should not be used by individuals with known allergies or sensitivities to peptide compounds or copper, or by those who are pregnant, nursing or have active malignancies.
The long-term effects and safety profile of this peptide blend have not been established in any population. Research on these peptides is still in the early stages.
Medical advice is particularly important for individuals with autoimmune conditions, copper metabolism disorders, Wilson's disease, cancer or a history of cancer, or those taking medications that affect immune function or copper levels. This peptide blend should not be used during pregnancy or breastfeeding.
The product should also be stored securely to prevent accidental access or use by children or other household members, particularly after reconstitution when it contains a liquid solution.
BPC-157, TB-500, and GHK-CU are not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. KPV is also not specifically listed. Athletes should check the current list before competition, as prohibited substances are subject to change. Some peptide compounds may fall under general prohibitions on substances with similar biological effects.
The current status and applicable rules can be checked through the World Anti-Doping Agency Prohibited List.
Common Product Questions
Quick answers about Klow 80 mg specifications, storage, shipping, Bitcoin payment and general product information.
Dragon Pharma Klow 80 mg is a lyophilized peptide product containing a blend of BPC-157 (10 mg), TB-500 (10 mg), KPV (10 mg), and GHK-CU (50 mg) per vial. It is supplied in a 2 mL vial for research purposes.
Klow contains four peptides: BPC-157 (10 mg), TB-500 (10 mg), KPV (10 mg), and GHK-CU (50 mg), for a total of 80 mg per vial.
Each vial contains 10 mg of BPC-157, 10 mg of TB-500, 10 mg of KPV, and 50 mg of GHK-CU.
The product is supplied as a lyophilized powder in a 2 mL vial. It requires reconstitution with bacteriostatic water or sterile water for injection before use.
Store the lyophilized powder in its original packaging at room temperature or refrigerated, protected from excessive heat, moisture and direct light. Once reconstituted, peptide solutions typically require refrigeration and should be used within a limited timeframe. Always follow the specific storage directions printed on the product label.
Lyophilized peptide powders are generally stable at room temperature but should be protected from heat. After reconstitution, peptide solutions typically require refrigeration. Check the product label for specific storage instructions.
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy Klow 80 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
The peptides in Klow are not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. Athletes should check the current list before competition, as prohibited substances are subject to change.
Additional research on BPC-157, TB-500 (thymosin beta-4), KPV, and GHK-CU is available through the National Institutes of Health and other scientific databases. Direct links to PubMed references are provided in the Science & Research section above.